GGrantIndex
← Leaderboards

Hua Lu

Tulane University Of Louisiana

$18,463,532
Attributed
$20,352,698
Total exposure
12
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$20,352,698 · 12

By mechanism

R01$16,245,324 · 7
U01$2,991,489 · 1
R21$1,108,085 · 3
R13$7,800 · 1

Top collaborators

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsMalignant NeoplasmsProteinsResponsePlayPathway InteractionsStressMolecularTumorigenesisLightTp53 GeneCancer CellCell GrowthTumorMediatingFeedbackRegulationBiochemicalAffectProtein P53InsightComplexAnimalsGenes

Grant awards (73)

Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples$575,420
U01 · FY2024 · CA
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples$566,198
U01 · FY2023 · CA
The Role of p53-R249S’s GOF in HCC development$354,023
R01 · FY2023 · CA · contact PI
Validating p53 Ser46 crotonylation as a potential target for possible anti-cancer therapy$210,291
R21 · FY2023 · CA · contact PI
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples$603,481
U01 · FY2022 · CA
The Role of p53-R249S’s GOF in HCC development$351,610
R01 · FY2022 · CA · contact PI
Validating p53 Ser46 crotonylation as a potential target for possible anti-cancer therapy$177,650
R21 · FY2022 · CA · contact PI
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples$615,433
U01 · FY2021 · CA
The Role of p53-R249S’s GOF in HCC development$366,924
R01 · FY2021 · CA · contact PI
The Role of Ribosomal Proteins in the P53-MDM2 Pathway$285,950
R01 · FY2021 · CA · contact PI
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples$630,957
U01 · FY2020 · CA · contact PI
The Role of p53-R249S’s GOF in HCC development$364,509
R01 · FY2020 · CA · contact PI
The Role of Ribosomal Proteins in the P53-MDM2 Pathway$285,950
R01 · FY2020 · CA · contact PI
The Role of p53-R249S’s GOF in HCC development$390,301
R01 · FY2019 · CA · contact PI
Role of the AMPK-MDMX-p53 pathway in cancer$312,042
R01 · FY2019 · CA · contact PI
The Role of Ribosomal Proteins in the P53-MDM2 Pathway$277,371
R01 · FY2019 · CA · contact PI
Role of the AMPK-MDMX-p53 pathway in cancer$321,694
R01 · FY2018 · CA · contact PI
The Role of Ribosomal Proteins in the P53-MDM2 Pathway$285,950
R01 · FY2018 · CA · contact PI
Role of the AMPK-MDMX-p53 pathway in cancer$321,694
R01 · FY2017 · CA · contact PI
The Role of Ribosomal Proteins in the P53-MDM2 Pathway$285,950
R01 · FY2017 · CA · contact PI
Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppression$163,669
R21 · FY2017 · CA · contact PI
Role of the AMPK-MDMX-p53 pathway in cancer$321,694
R01 · FY2016 · CA · contact PI
Dual Targeting of the p53 pathway for development of anti-cancer therapy$312,733
R01 · FY2016 · CA · contact PI
Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppression$196,403
R21 · FY2016 · CA · contact PI
Targeting GRP78 for p53 activation as anti-cancer therapy$163,669
R21 · FY2016 · CA · contact PI
Role of the AMPK-MDMX-p53 pathway in cancer$321,684
R01 · FY2015 · CA · contact PI
Dual Targeting of the p53 pathway for development of anti-cancer therapy$312,733
R01 · FY2015 · CA · contact PI
The role of ribosomal proteins in the p53-MDM2 pathway$265,220
R01 · FY2015 · CA · contact PI
Targeting GRP78 for p53 activation as anti-cancer therapy$196,403
R21 · FY2015 · CA · contact PI
The Eighth International Mdm2 Workshop$7,800
R13 · FY2015 · CA · contact PI
Dual Targeting of the p53 pathway for development of anti-cancer therapy$303,351
R01 · FY2014 · CA · contact PI
The role of ribosomal proteins in the p53-MDM2 pathway$256,973
R01 · FY2014 · CA · contact PI
Dual Targeting of the p53 pathway for development of anti-cancer therapy$299,836
R01 · FY2013 · CA · contact PI
The role of ribosomal proteins in the p53-MDM2 pathway$248,752
R01 · FY2013 · CA · contact PI
Role of ribosomal proteins in regulating c-Myc$302,919
R01 · FY2012 · CA · contact PI
Dual Targeting of the p53 pathway for development of anti-cancer therapy$294,134
R01 · FY2012 · CA · contact PI
The role of ribosomal proteins in the p53-MDM2 pathway$293,343
R01 · FY2012 · CA · contact PI
Role of ribosomal proteins in regulating c-Myc$303,925
R01 · FY2011 · CA · contact PI
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway$183,210
R01 · FY2011 · CA · contact PI
The role of ribosomal proteins in the p53-MDM2 pathway$118,061
R01 · FY2011 · CA · contact PI
The role of ribosomal proteins in the p53-MDM2 pathway$109,898
R01 · FY2011 · CA · contact PI
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway$92,011
R01 · FY2011 · CA · contact PI
Role of ribosomal proteins in regulating c-Myc$313,325
R01 · FY2010 · CA · contact PI
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway$283,825
R01 · FY2010 · CA · contact PI
The role of L5, L11 and L23 in the MDM2-p53 feedback regulation$256,612
R01 · FY2010 · CA · contact PI
Role of ribosomal proteins in regulating c-Myc$313,325
R01 · FY2009 · CA · contact PI
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway$283,914
R01 · FY2009 · CA · contact PI
The role of L5, L11 and L23 in the MDM2-p53 feedback regulation$256,612
R01 · FY2009 · CA · contact PI
Role of ribosomal proteins in regulating c-Myc$294,277
R01 · FY2008 · CA · contact PI
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway$284,002
R01 · FY2008 · CA · contact PI
The role of L5, L11 and L23 in the MDM2-p53 feedback regulation$252,377
R01 · FY2008 · CA · contact PI
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway$284,931
R01 · FY2007 · CA · contact PI
The role of L5, L11 and L23 in the MDM2-p53 feedback regulation$256,612
R01 · FY2007 · CA · contact PI
The role of L5, L11 and L23 in the MDM2-p53 feedback regulation$4,235
R01 · FY2007 · CA · contact PI
Study of a FACTp140-SSRP1-associated p53 Kinase$286,481
R01 · FY2006 · CA · contact PI
The role of L5, L11 and L23 in the MDM2-p53 feedback regulation$267,838
R01 · FY2006 · CA · contact PI
Molecular Dissection of a Novel P53-like Protein$196,300
R01 · FY2006 · CA · contact PI
Molecular Dissection of a Novel P53-like Protein$98,971
R01 · FY2006 · CA · contact PI
Study of a FACTp140-SSRP1-associated p53 Kinase$7,550
R01 · FY2006 · CA · contact PI
Molecular Dissection of a Novel P53-like Protein$302,378
R01 · FY2005 · CA
Study of a FACTp140-SSRP1-associated p53 Kinase$301,152
R01 · FY2005 · CA
The Interplay Between the Repressor MDM2 and Coactivator$268,780
R01 · FY2005 · CA
Molecular Dissection of a Novel P53-like Protein$302,378
R01 · FY2004 · CA
Study of a FACTp140-SSRP1-associated p53 Kinase$299,427
R01 · FY2004 · CA
The Interplay Between the Repressor MDM2 and Coactivator$268,780
R01 · FY2004 · CA
Study of a FACTp140-SSRP1-associated p53 Kinase$287,013
R01 · FY2003 · CA
Molecular Dissection of a Novel P53-like Protein$286,945
R01 · FY2003 · CA
The Interplay Between the Repressor MDM2 and Coactivator$268,780
R01 · FY2003 · CA
Molecular Dissection of a Novel P53-like Protein$284,085
R01 · FY2002 · CA
Study of a FACTp140-SSRP1-associated p53 Kinase$283,995
R01 · FY2002 · CA
The Interplay Between the Repressor MDM2 and Coactivator$268,780
R01 · FY2002 · CA
MOLECULAR DISSECTION OF A NOVEL P53 LIKE PROTEIN$171,092
R01 · FY2001 · CA
MOLECULAR DISSECTION OF A NOVEL P53 LIKE PROTEIN$166,107
R01 · FY2000 · CA